Orthofix Medical Inc. (NASDAQ:OFIX) Stock Holdings Boosted by Juniper Investment Company LLC

Juniper Investment Company LLC raised its stake in Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 123.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,937,249 shares of the medical device company's stock after buying an additional 1,070,656 shares during the period. Orthofix Medical comprises 13.3% of Juniper Investment Company LLC's holdings, making the stock its 4th biggest holding. Juniper Investment Company LLC owned about 5.07% of Orthofix Medical worth $33,824,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in OFIX. JPMorgan Chase & Co. raised its holdings in shares of Orthofix Medical by 244.1% in the 4th quarter. JPMorgan Chase & Co. now owns 290,351 shares of the medical device company's stock valued at $5,070,000 after purchasing an additional 205,972 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Orthofix Medical by 31.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 659,475 shares of the medical device company's stock valued at $11,515,000 after purchasing an additional 159,177 shares in the last quarter. Emerald Mutual Fund Advisers Trust raised its holdings in shares of Orthofix Medical by 35.4% in the 4th quarter. Emerald Mutual Fund Advisers Trust now owns 503,802 shares of the medical device company's stock valued at $8,796,000 after purchasing an additional 131,653 shares in the last quarter. Boone Capital Management LLC raised its holdings in shares of Orthofix Medical by 13.6% in the 4th quarter. Boone Capital Management LLC now owns 1,057,313 shares of the medical device company's stock valued at $18,461,000 after purchasing an additional 126,806 shares in the last quarter. Finally, Emerald Advisers LLC raised its holdings in shares of Orthofix Medical by 12.2% in the 4th quarter. Emerald Advisers LLC now owns 822,377 shares of the medical device company's stock valued at $14,359,000 after purchasing an additional 89,717 shares in the last quarter. 89.76% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently commented on OFIX. Canaccord Genuity Group restated a "buy" rating and issued a $24.00 price target on shares of Orthofix Medical in a report on Wednesday, February 26th. Roth Mkm reiterated a "buy" rating and set a $22.00 price objective on shares of Orthofix Medical in a research note on Wednesday, February 26th. Finally, StockNews.com lowered shares of Orthofix Medical from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th.

Orthofix Medical Stock Performance

Orthofix Medical stock traded down $0.06 during mid-day trading on Friday, reaching $12.14. 409,965 shares of the company traded hands, compared to its average volume of 261,756. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.39 and a quick ratio of 1.11. Orthofix Medical Inc. has a fifty-two week low of $10.50 and a fifty-two week high of $20.73. The company has a market capitalization of $473.73 million, a price-to-earnings ratio of -3.88 and a beta of 0.87. The firm's fifty day moving average is $14.49 and its two-hundred day moving average is $16.81.

Insider Buying and Selling at Orthofix Medical

In other news, insider Lucas Vitale sold 4,287 shares of the company's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $16.60, for a total value of $71,164.20. Following the sale, the insider now directly owns 135,317 shares of the company's stock, valued at $2,246,262.20. This represents a 3.07% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Massimo Calafiore acquired 10,000 shares of the company's stock in a transaction dated Friday, May 9th. The stock was acquired at an average cost of $12.54 per share, for a total transaction of $125,400.00. Following the completion of the acquisition, the chief executive officer now directly owns 234,603 shares in the company, valued at approximately $2,941,921.62. The trade was a 4.45% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have sold 8,475 shares of company stock worth $128,065. 1.30% of the stock is owned by corporate insiders.

Orthofix Medical Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.